CytoMed Therapeutics Limited (GDTC)

Oncternal Therapeutics Revenue

In the year 2024, CytoMed Therapeutics had annual revenue of 503.37K SGD, down -0.86%. CytoMed Therapeutics had revenue of 279.19K in the half year ending December 31, 2024, a decrease of -3.52%.

• Revenue (ttm): 503.37K SGD
• Revenue Growth: -0.86%
• P/S Ratio: 58.82
• Revenue / Employee: 11,706 SGD
• Employees: 43
• Market Cap: 21.70M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	503.37K	-4.36K	-0.86%
Dec 31, 2023	507.74K	143.82K	39.52%
Dec 31, 2022	363.91K	250.07K	219.67%
Dec 31, 2021	113.84K	54.37K	91.43%
Dec 31, 2020	59.47K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.